Additional file 1 of Oncogenetic landscape and clinical impact of IDH1 and IDH2 mutations in T-ALL

Additional file 1. Supplemental Table 1: Custom capture Nextera XT gene panel. Supplemental Table 2: IDH1 and IDH2 mutations identified in 1085 patients with T-ALL. Supplemental Table 3: Chemotherapy in the FRALLE 2000 standard risk group T1 and high risk T2.